Sign up to get day trading & penny stock pick profile alerts in your email
ahead of the pack.
Email subscribers are notified of new profiles prior to it being posted to our website
Fleet Management Solutions Inc. is a company which was established in order to provide a full spectrum of automobile fleet solutions, all over the Country of Greece as well as the Balkans area.
The solutions that are offered by Fleet Management Solutions Inc. are covering all the after sales management needs of the companies that provide Automotive Leasing solutions.
The Company's extended experience in the automobile business allows for the maintaining of a privileged position versus the competition, facilitating the opportunity to provide not only first class services, but also reduced cost solutions.
Geovax HIV/AIDS Vaccines: Are currently in Human Clinical Trials across the USA, at major universities Are Designed for Predominant AIDS Virus Subtypes Use DNA & Viral Vector Technologies Demonstrated Excellent Preclinical Results: near 100% protection Completed Satisfactory Phase I Human Trial with prototype DNA Vaccine
Vaccines: The most cost effective way to combat Infectious Diseases Large global AIDS Vaccine Market - $10 billion plus…… Customers: humans, all ages, sexes, races, nationalities, geographical regions
*Disclaimer: The Futuregems.com
Newsletter is an independent electronic publication committed to
providing our readers with factual information on selected publicly
traded companies. All companies are chosen on the basis of certain
financial analysis and other pertinent criteria with a view toward
maximizing the upside potential for investors while minimizing the
downside risk, whenever possible. Moreover, as detailed below, this
publication accepts compensation from certain of the companies which
it features. Likewise, this newsletter is owned by Drinnis Holdings
Inc. To the degrees enumerated herein, this newsletter should not be
regarded as an independent publication.
From time to time Drinnis Holdings Inc sells shares in the open
market it receives as compensation for coverage of client companies.
Since the shares are received as compensation for services as
previously disclosed, and not for investment purposes, the editors
do not view the sale of the shares as contradictory to any advice
delivered in the content. This should be viewed as a conflict of
interest by shareholders or prospective shareholders of the client
companies. All stock quotes are delayed and should not be used for investment purposes.
All statements and expressions are the sole opinions of the editors
and are subject to change without notice. A profile, description, or
other mention of a company in the newsletter is neither an offer nor
solicitation to buy or sell any securities mentioned. While we
believe all sources of information to be factual and reliable, in no
way do we represent or guarantee the accuracy thereof, nor the
statements made herein. Click Here
to Learn More ::::